Hosted on MSN

Alzheimer’s pill could reduce brain decline in some high-risk patients, trial suggests

An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ...

‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s

This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved ...
Houston Public Media

An Alzheimer's pill appears to protect some in a high-risk population

In April, the future was looking bleak for an experimental Alzheimer's drug called valiltramiprosate, or ALZ-801. Researchers had just released topline results of a study of more than 300 people age ...
AOL

First Alzheimer's pill for genetically at high risk shows promise in phase 3 trial

A new pill for those genetically at risk for Alzheimer’s has shown benefits in clinical trials. FotografiaBasica/Getty Images One gene variant that is particularly associated with Alzheimer’s disease ...
Hosted on MSN

Alzheimer’s drug trials hit record with broader treatment targets

A new UNLV-led report shows the global Alzheimer’s drug pipeline has grown to 192 active trials testing 158 drugs, a 35% rise ...
USA Today

Ozempic pill failed to slow Alzheimer's. But could it reveal new clues?

Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, can treat, despite high hopes and two years of study. The ...